Find your path to Udayan
75 people in our graph share verified history with Udayan — schools, employers, funds. One of them is your warm intro.
Karen KnudsenunlockedUdayan: together at National Cancer Institute (2018–2024)
×2Udayan: together at Albert Einstein College of Medicine
×4Udayan: together at National Cancer Institute
×3Udayan: together at NextCure
Executive at NextCure
Intro paths
→
In turn, Udayan can intro founders to NextCure's investors below.
NextCure's investors · 11
Bay City CapitalSan Rafael · $5M – $10M checksCanaan PartnersStamford · $500K – $20M checks · since 2015LAVHong Kong · $5M – $15M checksLilly Asia VenturesHong KongOrbiMedNew York · $1M – $75M checks · since 2015Pfizer Venture Investments$5M – $20M checksQuan CapitalShanghaiQuan VentureGrand CaymanSofinnova Venture PartnersMenlo ParkSofinnova VenturesMenlo Park · $100K – $15M checks · since 2025Taiho Ventures, LLCMenlo Park
Co-founders at NextCure
MR
Michael RichmanExecutive Officer, Director
Experience
- NextCure, Inc.Chief Medical Officercurrent2025 — presentBeltsville, Maryland, United States
- NextCure, Inc.Senior Vice President, Clinical and Translational Development2023 — 2025Beltsville, Maryland, United States
- Grannus TherapeuticsMember Board of Directorscurrent2025 — present
- National Cancer Institute (NCI), NIHSenior Clinical Advisory Staff-Special Volunteer2020 — 2026Bethesda, MD
- National Cancer Institute (NCI), NIHInvestigator and Physician2011 — 2020Bethesda, MD
- TCR² Therapeutics Inc.VP, Head of Clinical Development2022 — 2023
- Bristol Myers SquibbSenior Director, Early Clinical Development2021 — 2022Princeton, NJ
- Bristol Myers SquibbDirector, Early Clinical Development2020 — 2021Princeton Pike, NJ
- MSKCCMD PhD2005 — 2010New York, NY
Skills & more
Immunotherapy7Cancer Biology9Liquid Chromatography-Mass Spectrometry (LC-MS)5Mouse Models2Translational1Cellular TherapyCancer ImmunotherapyTranslational ResearchNeuroscienceGenomicsProteomicsClinical Development
+8 more
Drug DevelopmentMolecular BiologyOncologyClinical ResearchCancerCell BiologyLifesciencesClinical Trials- Diplomat, AMERICAN BOARD OF INTERNAL MEDICINE — American Board of Internal Medicine
- Diplomat, SUBSPECIALTY OF MEDICAL ONCOLOGY — American Board of Internal Medicine
- New York State Medical Licensure — American Board of Internal Medicine
From Udayan's professional profile.
Frequently asked questions
- Who is Udayan Guha?
- Executive Officer at NextCure
- Where does Udayan Guha work?
- Udayan Guha is Executive at NextCure.
- Where did Udayan Guha go to school?
- Udayan Guha studied at Memorial Sloan Kettering Cancer Center (Oncology Fellowship, Medical Oncology); Albert Einstein College of Medicine (Ph.D., Neuroscience); All India Institute of Medical Sciences (MBBS, Medicine).
Same school
Also attended Memorial Sloan Kettering Cancer Center7
Jakob DupontExecutive Partner, Private Equity at Sofinnova VenturesKevin DaiManaging Director at Vivo CapitalSteven SoignetGeneral Partner at Arcus VenturesDavid FeltquateAdvisor at RA CapitalJustin BekelmanExecutive Officer, Director at Daymark HealthClifford SolomonExecutive Officer, Director at Gibson Oncology
+ 1 more
Also attended Albert Einstein College of Medicine21
Perry NisenExecutive Advisor, Private Equity at Sofinnova VenturesRichard StumacherClinical Advisor at Seae VenturesScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesSam GoldbergerManaging Partner at Ambit Health VenturesGur RoshwalbPartner at aMoonDr. Yair SapersteinFounder / CEO at Avo
+ 15 more
Also attended All India Institute of Medical Sciences7
Shreeram AradhyeInvestor at Novartis Venture FundVikas GoelFounder at ZafrensCherian DrFounder at Synapsica HealthcareGandharv GoyalFounder at Synapsica HealthcareDr Arbinder SingalHead, Preventive & Digital Health at FitterflyKishlay AnandCEO; Manager of Manager of Issuer at Akos MD
+ 1 more
Shared employers
Also worked at NextCure, Inc.2
Also worked at National Cancer Institute (NCI), NIH38
Pamela KleinVenture Partner at Ysios CapitalKaren KnudsenAdvisor at Oncology VenturesFrank RimalovskiExecutive Director at NYU Innovation Venture FundVincent OssipowPartner at Omega FundsElizabeth Cho-FertikhManaging Partner at MEDA VenturesDr. Noé E. CrespoAssociate Director at Parallel 18
+ 32 more
Also worked at Bristol Myers Squibb156
Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners
+ 150 more
Also worked at MSKCC68
Neil NagVenture Partner at Moment Ventures, LlcBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalTarek El-SawyVenture Partner at RaivenStella PaffenholzSenior Associate at Atlas VentureMaurizio FazioPrincipal at Atlas VentureAlley (Welsh) OlshanskyAdvisor at Casdin Capital
+ 62 more








































